Gilead Sciences bags Descovy FDA approval for prevention of HIV infection

pharmanewsdaily- December 1, 2019

Descovy FDA approval : Gilead Sciences’ Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF) has been approved by the US Food and ... Read More